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The role of cholecystokinin (CCK) in modulating feed intake depression in parasite-infected 
lambs was investigated using CCK receptor antagonists (L364-7 18 and loxiglumide). Four 
experiments were carried out using ewe lambs infected with 4000 Trichostrongylus 
colubrifonnis larvae/d or non-infected controls (n 8, live weight 25 kg). Animals were fed 
daily on a nutritionally complete pelleted diet and had free access to water. In the first 
experiment, infected and non-infected animals were injected subcutaneously with CCK 
antagonist (100pg L364-718) or carrier alone as a single dose. In the second experiment, CCK 
antagonist (loxiglumide: 0, 5, 10 or 20mg/kg live weight) was injected into a jugular vein 
immediately before feeding. In the third experiment, animals were infused continuously with the 
CCK antagonist (loxiglumide; 10 mg/kg per h) for 10 min before feeding and for the first 2 h of 
feeding. In the final experiment, lambs were fitted with an indwelling cerebral ventricular 
cannula and infused with a CCK antagonist (loxiglumide, 162 pg/min), CCK agonist (CCK-8, 
2.5pmol/min), loxiglumide plus CCK-8 or sterile saline solution alone via the cannula for 
30 min before feeding and for the first 60 min of feeding. In all the experiments short-term feed 
intake was recorded at 10 and 15min intervals for the first and second hours of feeding 
respectively, then at hourly intervals for the remainder of the 8 h recording period. Peripheral 
injection with L364-718 or loxiglumide did not elevate feed intake in either the infected or non- 
infected animals. However, feed intake was increased (P < 0.05) in the short term by central 
infusion of loxiglumide, this effect being greater in the infected animals and apparently due to 
an elevation in intake during the second hour of feeding. CCK-8 depressed short term feed 
intake only in the infected animals (P < 0.05). Total daily feed consumption was not influenced 
by any of the pharmacological agents. The results indicate an involvement of central CCK 
receptors in regulation of feed intake depression following gastrointestinal parasitism of sheep 
and the possibility of a similar role in non-infected sheep. They do not support the singular 
importance of a peripheral action of CCK in determining satiety. 
Cholecystokinin: Loxiglumide: Feed intake: Gastrointestinal parasites 
Gastrointestinal parasite infection in growing lambs can 
lead to significant production losses, attributable to a re- 
duction in the efficiency of use of metabolizable energy and 
a reduction in voluntary feed intake (Poppi et al. 1990). 
Although a reduction in voluntary feed intake is commonly 
reported, little is known of the mechanisms of this de- 
pression. 
In the regulation of 'normal' intake it is highly 
improbable that a single pathway would regulate intake 
but the temporary /reversible nature of parasite induced 
intake depression suggests that a single pathway may cause 
the intake depression in this instance. Gastrointestinal 
hormones may be involved in such pathways and one of 
these, cholecystokinin (CCK), has been linked to intake 
depression in infected lambs (Symons & Hennessey, 1981). 
The action of CCK in causing such intake depression may 
involve any of at least three mechanisms. First, peripheral 
CCK stimulation of the brain via vagal afferents may have 
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a direct satiety effect (Hoebel, 1985). Second, release of 
CCK from sites along the gastrointestinal tract may alter 
the rate of gut emptying and therefore indirectly reduce 
intake. Finally, CCK from peripheral circulation may be 
secreted into cerebrospinal fluid and be transported to 
receptive sites within the brain. The possible role of CCK 
in the feed intake depression and changes to intestinal 
motility which accompany gastrointestinal worm infection 
have not been investigated beyond the original studies of 
Symons & Hennessy (1981). This line of investigation has 
been hindered by the lack of reliable assays to measure 
changes in circulating concentrations of CCK. An alter- 
native experimental approach for studying the role of CCK 
lies with the use of its antagonists, such as loxiglumide 
(CR1505, Rotta Research Laboratorium, Monza, Italy) and 
L364-718 (Merck, Sharpe and Dohme, Harlow, Essex, 
UK). In vitro and in vivo studies (Chang & Lotti, 1986; 
Setnikar et al. 19876) have shown that both these 
compounds are potent, specific antagonists of CCK 
receptors, with high affinity for the CCK-A receptors 
which occur mainly in peripheral tissues. 
Evidence exists for an involvement of CCK in central 
control of feed intake. For sheep Marson et al. (1986) have 
located specific CCK receptors in the hypothalamus and 
Morley et al. (1981) reported that fasting decreased CCK 
levels in this part of the brain of sheep. Injection of CCK 
into the cerebral ventricles of sheep reduced feed intake 
(Della-Fera & Baile, 1979) and injection of a CCK- 
antibody at the same site stimulated feeding (Della-Fera & 
Baile, 1981). Our hypothesis is that CCK mediates the 
anorexia in sheep caused by gastrointestinal parasitism. 
The present series of studies was designed to determine 
the role of CCK in parasite-infected sheep by examining 
the effects of CCK antagonists, administered systemically 
or centrally, on short-term feed intake and gut emptying. In 
particular we wished to determine whether intake depres- 
sion could be overcome in the short term by blockade of 
CCK receptors. 
Materials and methods 
Animals 
Four experiments used Coopworth x Dorset Down-cross 
ewe lambs, weaned at approximately 17 kg live weight and 
reared to minimize exposure to gastrointestinal parasites. 
When the average live weight was 25 kg, sixteen animals 
were ranked on the basis of live weight and randomly 
allocated to a parasite-infected or non-infected group (n  8). 
Infected animals received 4000 Trichostrongylus colubri- 
formis larvae/d administered orally as bulked doses three 
times/week on filter paper, while non-infected animals 
received only moistened filter paper tablets. 
Feeding and measurement of feed intake 
A complete pelleted ration was offered ad libitum in all 
experiments. Diet composition was (g/kg): cereal straw 
300, barley grain 490, field peas 200 and trace elements 10. 
Average proximate analysis was (g/kg): crude protein 185, 
fat 15 and neutral-detergent fibre 312. Feed refusals were 
removed daily at 07.30 hours and all animals were deprived 
of food for 2 h, to standardize the time of the first meal at 
09.30 hours. Short term feed intake was recorded over 8 h 
by weighing feed remaining at 10 min intervals for the first 
hour, 15 min intervals for the second hour and hourly for 
the remainder of the 8 h measurement period. Daily feed 
intake (consumed over the 22 h period in which feed was 
available) was determined each day from feed offered 
minus refusals. 
Parasitology 
Faeces were taken manually from the rectum of each lamb 
on a weekly basis and processed immediately to determine 
faecal egg concentration by a modified McMaster method 
(Ministry of Agriculture, Fisheries and Food, 1979). 
Animals were weighed weekly at 08.00 hours before 
feeding except during treatment runs. 
Experimental design and procedures 
In each experiment administration of treatments com- 
menced when daily feed intake was depressed by at least 
20 % in infected lambs. At the completion of the treatment 
period, all animals were orally dosed with anthelmintic 
(200 pg ivermectin/kg live weight, Ivomec, Merck, Sharp 
and Dohme) and short term and daily feed intake monitored 
during intake recovery. All procedures used in these studies 
were conducted with prior approval from the Lincoln 
University Ethics of Animal Experimentation Committee. 
Expt 1: single dose ,study (L364-718) 
The CCK antagonist L364-'718 was administered to 
infected and non-infected lambs ( n 8 )  as a single dose 
using a replicated Latin square design. At 15min before 
feeding lambs were injected subcutaneously with 100 pg of 
the CCK antagonist (L364-718, Merck, Sharp and Dohme) 
which had been dissolved in 0.5ml dimethyl sulfoxide 
under sterile conditions. 
Expt 2: dose-response study (loxiglumide) 
A replicated duplicate Latin square design (eight infected 
animals paired with eight non-infected animals receiving 
two replicates of each of four treatments) was used to 
determine the dose-response relationship between loxiglu- 
mide and feed intake. Immediately before feeding animals 
were injected intravenously with 0, 5, 10 or 20mg 
loxiglumide (Rotta Research Laboratorium) per kg live 
weight via a temporary indwelling catheter into a jugular 
vein (16G x 50mm, 51mm x 1.3mm i.d., Surflo i.v. 
catheter, Terumo Corporation, Tokyo, Japan). Loxiglumide 
was supplied in sterile glass vials containing 5.4g/l of 
sodium salt of loxiglumide in phosphate-buffered saline 
solution, the zero dose (0 mg) consisting of phosphate- 
buffered saline solution only. Prepared solutions were 
drawn from sterile vials into 60ml syringes. Each syringe 
was attached directly onto the catheter and the solution 
infused steadily over 2-3 min. 
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Expt 3: continuous infusion study (loxiglumide) 
The study of effects of continuous infusion of the CCK 
antagonist was run in two parts. At three weeks before the 
commencement of the experiment, all animals were 
surgically fitted with an abomasal cannula (Hecker, 1974). 
Following the onset of feed intake depression, 
infected and non-infected lambs (n 6) were infused with 
loxiglumide for 130min via a temporary indwelling 
catheter (as for Expt 2) into a jugular vein. Loxiglumide 
powder was dissolved in sterile phosphate-buffered saline 
solution which had been adjusted to pH 7.6 to increase 
solubility and the resulting 10 mg/ml solution was filtered 
through a bacterial filter (0.2 pm cellulose acetate filter, 
Advantec, Toyo Roshi Kaisha Ltd, Japan). The infusion 
was via gravity feed, using sterile tubing. Initially the 
solution was administered at a rate of 1 ml/min for 10 min. 
The infusion rate was reduced to 0.3 ml/min (approxi- 
mately 10mg/kg per h) for the remaining 2h, as 
recommended to maintain a steady state level of loxiglu- 
mide in circulation (L Rovati, Rotta Research Laborator- 
ium, personal communication). Sheep were fed following 
the initial 10 min infusion and intake recorded as described 
earlier. The procedure was repeated using the saline 
solution alone on another day. 
In Part 2, the procedure was carried out as for 
Part 1 with the addition of a single dose of radioactive 
marker, the 51Cr complex of EDTA (10ml solution 
containing 6 MBq 51CrEDTA, Amersham Australia Pty 
Ltd, Australia). This was injected into the abomasum via 
the abomasal cannula 45min after feeding, a time which 
corresponded to the end of the first eating period. Abomasal 
samples were then collected at 15, 30, 45, 60, 75, 90, 105, 
120 and 135min following injection. Each sample was 
immediately mixed and a lOml portion taken for 
determination of radioactivity using a gamma scintillation 
spectrometer (1282 Compugamma Universal Gamma 
Counter; LKE? Wallac, Turku, Finland). The samples and 
standards were stored at 4" until counted, within 4 d  of 
collection. Calculation of abomasal volume, flow and 
retention time was carried out by marker analysis using 
regression analysis on the natural logarithms of the adjusted 
radioactivity counts (Faichney, 1975). 
Part 1. 
Part 2. 
Expt 4: continuous infusion into a lateral ventricle of the 
brain (CCK-8 and loxiglumide) 
Infected and non-infected lambs (n 8) were fitted surgically 
with a stainless steel cannula (20mm x 1 mm i.d.) 
chronically implanted into a lateral cerebral ventricle 
(GSG Spencer, personal communication) 2 weeks after 
parasite dosing commenced. This ensured a minimum post- 
operative period of 3 weeks before the infusions were 
carried out. 
Intracerebroventricular treatments 1-4 (following) were 
randomly allocated using a Latin square design and the 
solutions were infused at a rate of 0-03 ml/minute for 
90min; 30min before feeding and for the first hour 
following feeding. Treatment 1: sterile phosphate-buffered 
saline solution, pH 7.0 (control). Treatment 2: CCK-8 
in sterile phosphate-buffered saline solution (CCK-8 
( T Y ~ ( S O ~ H ) ~ ~ ) ,  fragment 26-33, product no. 9271, Sigma 
Chemical Co. St Louis, MO, USA) infused at 2.5 pmol/niin 
(CCK). Treatment 3: 5.4g/l (w/v) of sodium salt 
loxiglumide (162 pg loxiglumide/min) in sterile phosphate- 
buffered saline solution (CCK antagonist). Treatment 4: 
CCK-8 as in treatment 2 plus loxiglumide as in treatment 3 
(CCK plus antagonist). Treatment solutions were drawn 
into sterile 3 ml syringes connected to sterile tubing (1 mm 
i.d.) infusion lines and infused using a multichannel syringe 
pump. After 30 min of continuous infusion all animals were 
fed and intake recording commenced as described earlier. 
Infusion continued for the next 60min so that a total of 
90 min infusion occurred. 
Statistical methods 
Cumulative feed intake data did not meet the assumptions 
of normality, so a general linear model (GLM, SAS 6.1, 
Statistical Analysis Systems Institute, Cary, NC, USA) for 
unbalanced data was carried out on the ranked values (non- 
parametric analysis) and least square differences used to 
test differences between means. Rank values have no 
biological meaning, so data are presented as raw means. 
Means of abomasal volume, flow, retention time and the 
time taken for half the radioactive counts to leave the 
abomasum (t%) were tested using GLM and a Duncan's 
new multiple range test for differences between individual 
means. 
Results 
Live weigh1 
Mean live weight increased in both infected and non- 
infected lambs in all experiments. Non-infected lambs 
gained more weight (4-7, 4-3, 9.8 and 2.2 kg) than infected 
lambs in Expts 1-4 respectively. The increased weight gain 
was significant in Expts 2 and 3 but not in Expts 1 and 4. 
Faecal egg counts 
Mean and peak production of T. colubriformis eggs in 
infected lambs was between 1000 and 2000 eggs/g faeces, 
except for Expt 3 where mean and peak egg output values 
were 5500 and 9000/g respectively. 
Daily feed intake 
The daily intake by non-infected animals was 90-140 g 
DM/kg metabolic body weight (W@75) across all 4 ex- 
periments. Parasite-induced intake depression was usually 
significant 5-6 weeks after trickle dosing commenced 
(Fig. 1). The daily intake of infected animals during intake 
depression was 50-1 10 g DM/kg W0'75. Intake depression 
in the infected animals ranged from 10 to 60% and 
treatments were imposed when intake depression was in the 
range 3 0 4 0 %  (Fig. 1). 
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Fig. 1. Average daily feed intake of lambs infected with the parasite 
Trichostrongylus colubriformis as a percentage of the intake by their 
non-infected counterparts in four different experiments with chole- 
cystokinin antagonists: (0), single dose (Expt 1); (A), dose- 
response (Expt 2); (.), continuous infusion (Expt 3) and (A), 
intracerebroventricular infusion (Expt 4). For details of procedures, 
see pp. 48-49. 
short-term intake 
Short-term cumulative feed intake values for the infected 
lambs before, during intake depression and following 
intake recovery after anthelmintic treatments are shown 
in Fig. 2. Short-term cumulative feed intake was sig- 
nificantly lowered at all recorded time intervals during 
intake depression in infected animals (weeks 8-12). 
Following anthelmintic treatment and recovery of daily 
intake, short term feed intake returned to pre-infection 
levels. 
Effects of pharmacological agents 
Neither a single subcutaneous dose of L364-7 18 (results 
not presented) nor increasing doses of intravenous 
loxiglumide (Fig. 3) or continuous infusion of loxiglumide 
(Fig. 4) significantly increased short term feed intake in 
either infected or non-infected sheep at any recorded time 
period. Nevertheless, some trends were discernible. With 
increasing dose of loxiglumide there was a trend toward 
increased feed intake in the infected animals (Fig. 3) 
whereas non-infected animals tended to have reduced feed 
intake with increasing dose or infusion of loxiglumide 
(Figs. 3 and 4). 
CCK-8 infused alone into a lateral ventricle of the brain 
for 30min before feeding and for the first hour of feeding 
reduced feed intake of the infected animals in the first hour 
(Fig. 6). The resulting reduction in intake (41-55 %) was 
significant for 7 h after feeding (0.05 > P > 0.001) (Fig. 6). 
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Fig. 2. Mean daily cumulative feed intake (g/kg body weight' 75) of 
lambs (n 8) before infection with the parasite Trichostrongylus 
colubriformis (O), during infection (0) or following anthelmintic 
treatment and full intake recovery (A). Standard errors of the mean 
values are represented by vertical bars. 
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Fig. 3. Mean cumulative feed intake (g/kg body of lambs 
(n 8), infected or not infected with the parasite Trichostrongylus 
colubriformis, 1 h after feeding following intravenous injection of 0, 5, 
10 or 20mg/kg live weight of the cholecystokinin antagonist, 
loxiglumide. Standard errors of the mean values are represented 
by vertical bars. 
CCK-8 had no effect on the cumulative feed intake of non- 
infected animals (Fig. 5). 
Loxiglumide elevated feed intake in both non-infected 
and infected groups when infused into a ventricle of the 
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Infected Infected Infected 
Non-infected Non-infected Non-infected 
0-60 min 0- 180 min 0-420 min 
Fig. 4. Mean cumulative feed intake (g/kg body of lambs 
(n 8), infected or not infected with the parasite Trichostrongylus 
colubriformis, 60, 180 and 420min after feeding. Lambs were fed 
once daily and infused intravenously with saline solution (W) or the 
cholecystokinin antagonist, loxiglumide ( ) for 10 min before feeding 
and for the first 2 h of feeding. Standard errors of the mean values 
are represented by vertical bars. 
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Fig. 5. Mean cumulative feed intake (g/kg body of non- 
infected lambs (n 6) fed once daily and infused with saline solution 
(O), cholecystokinin octapeptide (CCK-8) (2.5 pmol/min; A), CCK 
antagonist (162pg/min; 0) or CCK-8 plus antagonist (A) into a 
lateral ventricle of the brain for 30 min before feeding and for the first 
hour after feeding. Standard errors of the mean values are 
represented by vertical bars. 
brain (Figs. 5 and 6). Loxiglumide increased intake 
gradually, with the increase becoming apparent at 30 rnin 
(P  < 0.1) and being significant (0-05 > P > 0.001) from 
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Fig. 6. Mean cumulative feed intake (g/kg body  eight""^) of lambs 
(n 6) infected with the parasite Trichostrongylus colubriformis fed 
once daily and infused with saline solution (O), cholecystokinin 
octapeptide (CCK-8,2.5 pmol/min, A), CCK antagonist (162 pg/min, 
0) or CCK-8 plus antagonist (A) into a lateral ventricle of the brain 
for 30min before feeding and for the first hour after feeding. 
Standard errors of the mean values are represented by vertical bars. 
40 min through to 4 h in the non-infected animals and until 
the end of short-term recording (7 h) in infected animals. 
Following the combined infusion of CCK-8 and 
loxiglumide into the lateral ventricle, feed intake was 
intermediate between that of the control (saline) and the 
loxiglumide alone (Figs. 5 and 6). In the infected groups the 
increases in intake above those of saline treatment were 
significant (P  < 0.05) from 1.75 h after feeding. In the non- 
infected groups cumulative intake of CCK-8 plus loxiglu- 
mide infused animals was significantly increased (P  < 0.05) 
above that of controls only between 40min and 3 h after 
feeding. 
Relative to controls loxiglumide infusion into the lateral 
ventricle of the brain increased the rate of eating by 75 o/c in 
the infected animals and 67 % in non-infected animals 
during the first hour of feeding. However the greatest effect 
was evident in the second hour of feeding when non- 
infected and infected animals ate 16 % (P  = 0.085) and 
188 % ( P  = 0.001) more feed, respectively, following 
loxiglumide infusion than in the same period following 
saline treatment. During the final period (2-7 h) the 
loxiglumide treatment effects were no longer apparent 
and both groups tended to eat less feed than their respective 
controls, being 36 % and 13 % less for the infected and non- 
infected groups respectively. As a result of the early 
stimulation of intake, the cumulative intake for infected 
animals treated with loxiglumide was still significantly 
higher than the control intake (34.1 (SE 4.3) v. 50.4 (SE 7.5), 
P<O.O5) at the end of the short term recording period 
(7 h). 
Between 1 and 2 h after feeding there was a significant 
(P<O.O5) infection x treatment interaction due to the 
infected animals suffering significant intake depression 
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Table 1. Abomasal volume (ml) and outflow rate (ml/min) of marker from the abomasum of infected and 
non-infected lambs (n  6) following intravenous infusion of saline solution or the cholecystokinin 
receptor antagonist, loxiglumide* 
(Mean values with their standard errors) 
Infected Non-infected 
Saline Loxiglumide Saline Loxiglumide 
Mean SE Mean SE Mean SE Mean SE 
Volume (ml) 67’ 11.3 80’ 18.5 162b 24.2 167b 27.9 
Outflow (ml/min) 2.2’ 0.17 2.5a 0.14 2.8b 0.12 2.ab 0.14 
Mean values within a row with unlike superscript letters were significantly different, P C  0.05. 
* For details of procedures, see pp. 48-49. 
following CCK-8 infusion when no effect was evident in 
the non-infected animals. Also the infected animals had a 
greater response to the intake-stimulating effects of 
loxiglumide. 
Good linear relationships of the natural log of the marker 
concentration v. time were obtained (2 > 0.9) for the data 
sets used in the prediction of abomasal volume and flow. 
The data indicate differences in the state of the abomasum 
in terms of volume and fractional outflow rate at a 
particular time. This is likely to be a function of the 
pattern of feeding as well as any specific effect on 
abomasal motility by the parasite. Parasite-infected sheep 
had a mean abomasal volume 60 % lower than that of non- 
infected animals (Table 1). Treatment with loxiglumide had 
no effect on abomasal volume or rate of outflow in either 
infected or non-infected groups. 
There was no significant (P>O-O5) effect of any 
pharmacological agent on total daily feed intake. All the 
observed effects were confined to the initial 7 h  of the 
feeding period, i.e. in the short term. 
Discussion 
These experiments have illustrated the nature of post- 
fasting feed intake in sheep with reduced daily intakes 
resulting from subclinical infection by T. colubrifonnis and 
they show that the intake depression can be reversed by 
administration of anthelmintics. More importantly, the 
finding that intracerebroventricular infusion of a CCK 
antagonist (loxiglumide) elevated feed intake in infected 
sheep supports the hypothesis that CCK is involved in 
appetite suppression of sheep with gastrointestinal parasit- 
ism. Furthermore it extends this hypothesis by linking the 
mechanism to central (brain) CCK receptors. 
In the present study, although gastrointestinal parasitism 
caused a depression of daily feed intake typical for T. 
colubrifomtis (Steel et al. 1980; Dynes et al. 1990, 1991), 
the changes in short term intake recorded here demonstrate 
for the first time that depression in daily intake results from 
a reduction in the rate of feed intake by infected animals, 
rather than from an effect on pattern of eating. 
The depression in daily intake and in the rate of eating 
was reversible. The rate of intake in the pre-infection 
period was similar in infected and non-infected animals, the 
parasitized group had a lower intake from about week 6 of 
infection and on administration of an anthelmintic their 
intake returned to the level of the non-infected group. This 
demonstrated that feed intake depression under parasitism 
can be examined by the cumulative intake model, making 
this a suitable tool for screening potentially therapeutic 
drugs. The differences were readily apparent in the first 
hour of feeding and in all subsequent periods recorded. 
Removal of the parasite reversed the short-term and daily 
intake depression, demonstrating that the presence of the 
parasite was instrumental in the feed intake depression. 
A link between changes in circulating gut hormones and 
intake depression mediated by parasite infection was first 
suggested by Symons & Hennessy (1981). The authors 
reported elevated circulating CCK levels during intake 
depression due to parasite infection. Intake depression due 
to a gut satiety hormone may be expected to change meal 
duration as reported for laboratory animals (Moran & 
McHugh, 1988). Such an effect was not observed in this 
study although the tendency of infected animals to ‘appear’ 
to be eating would have required a load cell attached to 
each feed bin to detect accurately these differences. 
A single dose of L364-718, increasing doses of 
loxiglumide or continuous infusion of loxiglumide failed 
to change short term feed intake in infected animals 
following systemic administration of these CCK antago- 
nists. This finding provides initial evidence to discount a 
role for the elevation of peripheral CCK concentration 
being the primary disturbance to feed intake in infected 
lambs, either directly or indirectly via CCK effects on gut 
emptying. 
Gastrointestinal parasite infections have been reported to 
alter gut motility and increase abomasal volume (Gregory 
et al. 1985b), but in the present study abomasal volume was 
reduced by 60 % in infected animals. This discrepancy can 
be accounted for by the differences in voluntary feed 
consumption between the two studies. Abomasal volumes, 
even in the non-infected animals, were much lower than 
those reported by Gregory et al. (1985a,b) (162 ml v. 300- 
900ml) and this is probably largely due to differences in 
feeding regimens between the two experiments. In the 
present study, to facilitate testing of pharmacological 
agents, sheep were fed once daily, whereas Gregory et al. 
(19854 used a continuous feeding regimen which produced 
steady-state rumen conditions and differences in the pattern 
of digesta flow from the gut compared with once daily 
feeding. The nature of the outflow from the abomasum 
could be quite different in the two circumstances, so it is 
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not possible to compare the parasite-induced effects on 
abomasal volume and emptying reported by Gregory et al. 
(19856) with the present findings. 
We could not validate the use of loxiglumide or L364- 
7 18 to block the action of peripheral CCK in sheep because 
we were unable to depress intake reliably with peripheral 
CCK administration. However, the response of the intake- 
depressed infected animals in this study was of particular 
interest. If, as Symons & Hennessy (1981) suggested, 
elevated peripheral CCK levels were depressing feed 
intake, then loxiglumide should have blocked these effects 
at least in the short term. Instead there was no change in 
feed intake of infected animals with a range of doses or 
continuous infusion of loxiglumide, even at dose rates 
double those which are used orally in human subjects to 
completely inhibit gall bladder contractions (Corazziari et 
al. 1990). This tends to rule out a role for peripheral CCK 
in parasite-induced feed intake depression of sheep. 
The effects of parasites on intake could be temporarily 
reversed. Loxiglumide elevated intake when infused 
directly into a lateral cerebral ventricle and this is the first 
evidence of a CCK receptor antagonist alleviating parasite- 
induced intake depression in lambs. This finding supports 
the view that central mechanisms have an important role in 
feed intake depression and specifically implicates centrally 
secreted CCK. Similar evidence has been obtained from 
studies with pigs (Parrott, 1993; Rayner & Miller, 1993; 
Baldwin et al. 1994). Loxiglumide is a pentanoic acid 
derivative which was originally developed as a therapeutic 
aid to manage CCK-dependent disorders in human subjects. 
Although loxiglumide has almost thirty times greater 
affinity for peripheral CCK than for central CCK receptors, 
its affinity for central receptors is still 19 000 times greater 
than that of proglumide, the original CCK antagonist 
(Setnikar et al. 1987~).  Studies on laboratory animals have 
demonstrated the antagonistic potency of loxiglumide on 
CCK-8-induced stimulation of gastrointestinal tissue 
(Setnikar et al. 19876). However, there are no published 
studies of its effects on feed intake in sheep, so direct 
comparisons with the present findings are not possible. 
Nevertheless, other CCK antagonists have been utilized 
successfully to increase feed intake in animals, for example 
CR 1409 in rats (Makovec et al. 1986) and MK-329 
(Rayner & Miller, 1993) or 2-NAP (Baldwin et al. 1994) in 
pigs. 
Loxiglumide infused into the lateral cerebral ventricle 
increased intake by changing the eating pattern in the first 
2 h of feeding. The rate of feed consumption was elevated 
in both the first and second hours of feeding, but the most 
marked change occurred in the second hour when the rate 
of consumption was elevated by 188 % in infected animals 
and by 16% in the non-infected group. Generally the 
second hour of feeding was observed to be a rest and/or 
rumination period in the usual eating pattern, but 
loxiglumide prolonged the meal, resulting in an almost 
continuous eating period, contrasting with the control 
treatments where animals stopped eating 40-60 min after 
feeding but had a second small meal between 1.25 and 2 h 
after feeding. Usually feeding was rapid for the first 20 min 
then declined to meal termination 40-50 min after feeding 
was initiated. Blockade of this effect by infusion of the 
CCK receptor antagonist led to a prolonged first meal in 
both the infected and non-infected animals. Although there 
was a significant elevation of feed intake in the short term, 
this was not manifested as changes to daily intake in either 
group, possibly due to other constraints on intake, such as 
reticulo-rumen fill which may have reduced intake later in 
the day. 
Intracerebroventricular infusion of the CCK octapeptide 
was very effective in reducing feed intake in the infected 
animals only, with the depression resulting in a much 
smaller than usual first meal followed by an extended 
intermeal interval, lasting between 2 and 3 h after feeding. 
Interestingly Della-Fera & Baile (1979), also using a 2h 
feed deprivation and 2.5 pmol/min intracerebroventricular 
infusion of CCK-8, found that healthy animals ate no feed 
at all for the duration of the 3 h infusion and as little as 
0.159 pmol/min CCK depressed intake by 85 % during the 
infusion period. In the present study there was no effect of 
CCK at all in non-infected animals and where it was 
effective in the infected animals the maximum recorded 
depression was only 52%. Similarly, Farningham et al. 
(1993) recorded no effect of CCK-8 on feed intake in 
healthy sheep when it was administered alone, by hepatic 
portal infusion. 
Conditioning to once daily feeding, as used in the present 
study, may lead to animals not eating for approximately 3 h 
before feed being offered then having a large meal of fresh 
feed (Forbes, 1980). Cumulative intake data recorded in the 
present study clearly depict the large initial meal the sheep 
ate immediately following provision of feed, so these 
animals may have had a greater hunger drive than would 
have been expected from a 2h  fast. However, CCK-8 
depressed feed intake by 53 5% in 8 h fasted animals during 
a 3 h infusion (Della-Fera & Baile, 1979), so it is surprising 
that a depression in feed intake in the non-infected animals 
of the present study was not seen during the 90niin 
infusion. 
Differing responsiveness to CCK-8 infusion between 
infected and non-infected animals may be due to the 
infected animals having higher levels of endogenous brain 
and/or central CCK activity acting directly on satiety 
centres, with the result that the addition of exogenous CCK 
was sufficient to precipitate a satiety signal and reduce 
intake accordingly. In the non-infected animals endogenous 
central CCK levels or activity may have been low (Scallett 
et al. 1985) and, despite the infusion, were insufficient to 
elicit satiety effects. 
Intracerebroventricular administration of loxiglumide 
not only increased the rate of consumption of feed but 
also appeared to increase the duration of the first meal. The 
response was greater in infected animals but the stimulation 
occurred in both groups and suggests an involvement of 
central CCK in feed intake regulation of sheep in general, 
rather than a role specific to the parasite-induced dis- 
turbance. 
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